Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912990831> ?p ?o ?g. }
- W2912990831 endingPage "236" @default.
- W2912990831 startingPage "236" @default.
- W2912990831 abstract "The modest successes of targeted therapies along with the curative effects of allogeneic hematopoietic stem cell transplantation (alloHSCT) in acute myeloid leukemia (AML) stimulate the development of new immunotherapies. One of the promising methods of immunotherapy is the activation of immune response by the targeting of negative control checkpoints. The two best-known inhibitory immune checkpoints are cytotoxic T-lymphocyte antigen-4 (CTLA-4) and the programmed cell death protein 1 receptor (PD-1). In AML, PD-1 expression is observed in T-cell subpopulations, including T regulatory lymphocytes. Increased PD-1 expression on CD8+ T lymphocytes may be one of the factors leading to dysfunction of cytotoxic T cells and inhibition of the immune response during the progressive course of AML. Upregulation of checkpoint molecules was observed after alloHSCT and therapy with hypomethylating agents, pointing to a potential clinical application in these settings. Encouraging results from recent clinical trials (a response rate above 50% in a relapsed setting) justify further clinical use. The most common clinical trials employ two PD-1 inhibitors (nivolumab and pembrolizumab) and two anti-PD-L1 (programmed death-ligand 1) monoclonal antibodies (atezolizumab and durvalumab). Several other inhibitors are under development or in early phases of clinical trials. The results of these clinical trials are awaited with great interest in, as they may allow for the established use of checkpoint inhibitors in the treatment of AML." @default.
- W2912990831 created "2019-02-21" @default.
- W2912990831 creator A5090085247 @default.
- W2912990831 date "2019-02-12" @default.
- W2912990831 modified "2023-10-05" @default.
- W2912990831 title "Targeting Immune Signaling Checkpoints in Acute Myeloid Leukemia" @default.
- W2912990831 cites W1533305218 @default.
- W2912990831 cites W1538902372 @default.
- W2912990831 cites W1544829530 @default.
- W2912990831 cites W1566018542 @default.
- W2912990831 cites W1763981524 @default.
- W2912990831 cites W1916138910 @default.
- W2912990831 cites W1940241680 @default.
- W2912990831 cites W1981463252 @default.
- W2912990831 cites W1983973479 @default.
- W2912990831 cites W1985106225 @default.
- W2912990831 cites W1991235944 @default.
- W2912990831 cites W2000112238 @default.
- W2912990831 cites W2001287101 @default.
- W2912990831 cites W2002478729 @default.
- W2912990831 cites W2007529060 @default.
- W2912990831 cites W2022772800 @default.
- W2912990831 cites W2033746426 @default.
- W2912990831 cites W2050574097 @default.
- W2912990831 cites W2057329290 @default.
- W2912990831 cites W2061429827 @default.
- W2912990831 cites W2061499620 @default.
- W2912990831 cites W2072043666 @default.
- W2912990831 cites W2073903271 @default.
- W2912990831 cites W2076956606 @default.
- W2912990831 cites W2079335705 @default.
- W2912990831 cites W2107752337 @default.
- W2912990831 cites W2108604103 @default.
- W2912990831 cites W2108933323 @default.
- W2912990831 cites W2115309559 @default.
- W2912990831 cites W2115917808 @default.
- W2912990831 cites W2123176392 @default.
- W2912990831 cites W2124060252 @default.
- W2912990831 cites W2130506153 @default.
- W2912990831 cites W2135707184 @default.
- W2912990831 cites W2141131774 @default.
- W2912990831 cites W2145871366 @default.
- W2912990831 cites W2153519961 @default.
- W2912990831 cites W2155464214 @default.
- W2912990831 cites W2158393416 @default.
- W2912990831 cites W2162889226 @default.
- W2912990831 cites W2166662937 @default.
- W2912990831 cites W2253000935 @default.
- W2912990831 cites W2299773969 @default.
- W2912990831 cites W2402976159 @default.
- W2912990831 cites W2521479161 @default.
- W2912990831 cites W2553022605 @default.
- W2912990831 cites W2559063149 @default.
- W2912990831 cites W2592785733 @default.
- W2912990831 cites W2604909450 @default.
- W2912990831 cites W2608745553 @default.
- W2912990831 cites W2616637874 @default.
- W2912990831 cites W2707748297 @default.
- W2912990831 cites W2732403960 @default.
- W2912990831 cites W2766430096 @default.
- W2912990831 cites W2767554110 @default.
- W2912990831 cites W2776548546 @default.
- W2912990831 cites W2789550990 @default.
- W2912990831 cites W2790226786 @default.
- W2912990831 cites W2796190150 @default.
- W2912990831 cites W2796760576 @default.
- W2912990831 cites W2890960212 @default.
- W2912990831 cites W2899030939 @default.
- W2912990831 cites W2900410545 @default.
- W2912990831 cites W2902244218 @default.
- W2912990831 cites W2903041954 @default.
- W2912990831 doi "https://doi.org/10.3390/jcm8020236" @default.
- W2912990831 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6406869" @default.
- W2912990831 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30759726" @default.
- W2912990831 hasPublicationYear "2019" @default.
- W2912990831 type Work @default.
- W2912990831 sameAs 2912990831 @default.
- W2912990831 citedByCount "44" @default.
- W2912990831 countsByYear W29129908312019 @default.
- W2912990831 countsByYear W29129908312020 @default.
- W2912990831 countsByYear W29129908312021 @default.
- W2912990831 countsByYear W29129908312022 @default.
- W2912990831 countsByYear W29129908312023 @default.
- W2912990831 crossrefType "journal-article" @default.
- W2912990831 hasAuthorship W2912990831A5090085247 @default.
- W2912990831 hasBestOaLocation W29129908311 @default.
- W2912990831 hasConcept C154317977 @default.
- W2912990831 hasConcept C202751555 @default.
- W2912990831 hasConcept C203014093 @default.
- W2912990831 hasConcept C2775949291 @default.
- W2912990831 hasConcept C2777701055 @default.
- W2912990831 hasConcept C2777742743 @default.
- W2912990831 hasConcept C2778729363 @default.
- W2912990831 hasConcept C2779282312 @default.
- W2912990831 hasConcept C2780030458 @default.
- W2912990831 hasConcept C2780057760 @default.
- W2912990831 hasConcept C2780851360 @default.
- W2912990831 hasConcept C502942594 @default.